Date | Insider | Price | Amount |
---|---|---|---|
12-16-2022 Insider Buy |
Michael I. Schaffer VP of Laboratory Operations |
$4.95 CAGR » |
$495.00 100 shares |
4-20-2022 Insider Buy |
Peter Kamin >10% Owner |
$6.59 CAGR » |
$284,423.96 43,143 shares |
4-8-2022 Insider Buy |
Peter Kamin >10% Owner |
$6.74 CAGR » |
$47,200.00 7,000 shares |
3-31-2022 Insider Buy |
Peter Kamin >10% Owner |
$6.89 CAGR » |
$85,516.20 12,403 shares |
12-11-2020 Insider Buy |
Fred J. Weinert Director |
$4.95 CAGR » |
$4,950.00 1,000 shares |
12-8-2020 Insider Buy |
Raymond C. Kubacki Jr. Chairman, CEO & President |
$5.00 CAGR » |
$5,000.00 1,000 shares |
11-18-2020 Insider Buy |
Michael I. Schaffer VP of Laboratory Operations |
$4.20 CAGR » |
$2,100.00 500 shares |
11-13-2020 Insider Buy |
Fred J. Weinert Director |
$3.92 CAGR » |
$7,840.00 2,000 shares |
11-12-2020 Insider Buy |
Raymond C. Kubacki Jr. Chairman, CEO & President |
$3.86 CAGR » |
$7,720.00 2,000 shares |
11-13-2020 Insider Buy |
A. Clinton Allen Director |
$3.99 CAGR » |
$7,980.00 2,000 shares |
6-14-2019 Insider Buy |
Raymond C. Kubacki Jr. Chairman, CEO & President |
$9.99 CAGR » |
$9,990.00 1,000 shares |
6-5-2019 Insider Buy |
Charles M. Doucot Vice President Sales & Mktg |
$9.90 CAGR » |
$4,950.50 500 shares |
11-14-2017 Insider Buy |
Raymond C. Kubacki Jr. Chairman, CEO & President |
$16.88 CAGR » |
$16,880.00 1,000 shares |
3-2-2016 Insider Buy |
Harry F. Connick Sr. Director |
$12.83 CAGR » |
$8,981.00 700 shares |
2-26-2016 Insider Buy |
Harry F. Connick Sr. Director |
$12.63 CAGR » |
$12,634.00 1,000 shares |
2-24-2016 Insider Buy |
Harry F. Connick Sr. Director |
$12.36 CAGR » |
$24,726.00 2,000 shares |
2-19-2016 Insider Buy |
Harry F. Connick Sr. Director |
$11.95 CAGR » |
$11,950.00 1,000 shares |
2-16-2016 Insider Buy |
Michael I. Schaffer VP of Laboratory Operations |
$11.09 CAGR » |
$49,982.63 4,507 shares |
6-15-2012 Insider Buy |
Neil Lerner VP - Finance |
$9.80 CAGR » |
$24,500.00 2,500 shares |
5-25-2011 Insider Buy |
Neil Lerner VP - Finance |
$10.01 CAGR » |
$59,008.95 5,895 shares |
3-17-2011 Insider Buy |
Neil Lerner Vice President and Controller |
$9.09 CAGR » |
$18,182.00 2,000 shares |
3-6-2009 Insider Buy |
Raymond C. Kubacki Jr. Chairman, CEO & President |
$4.27 CAGR » |
$4,269.00 1,000 shares |
Also See: Institutional Holders of PMD
Also See: SEC filings
Growth of $10,000.00 With Dividends Reinvested |
|||
Start date: | 12/19/2022 | ||
End date: | 04/18/2024 | ||
Start price/share: | $5.00 | ||
End price/share: | $2.56 | ||
Starting shares: | 2,000.00 | ||
Ending shares: | 2,054.64 | ||
Dividends reinvested/share: | $0.14 | ||
Total return: | -47.40% | ||
Average Annual Total Return: | -38.34% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $5,259.73 | ||
Years: | 1.33 | ||
Growth of $10,000.00 Without Dividends Reinvested |
|||
Start date: | 12/19/2022 | ||
End date: | 04/18/2024 | ||
Start price/share: | $5.00 | ||
End price/share: | $2.56 | ||
Dividends collected/share: | $0.14 | ||
Total return: | -46.00% | ||
Average Annual Total Return: | -37.11% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $5,399.60 | ||
Years: | 1.33 |
Psychemedics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Psychemedics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PMD
Free PMD Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |